Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases
NCT ID: NCT01189474
Last Updated: 2012-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
104 participants
INTERVENTIONAL
2010-06-30
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Its objective is to Collect information from patients and ophthalmologists specialized in ocular surface and eyelids to anticipate how Blephasteam ® can be optimized.
This study involves 2 visits, visit of Inclusion, J0, then end of study visit, D21.
Between the two visits patients will be treated with Blephasteam ® for 21 days (up to two uses per day) and complete a questionnaire every two days during the first week and then once a week the next two weeks.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blephasteam
Eye lid warming goggles
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
4 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laboratoires Thea
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean Paul ADENIS, Professor
Role: PRINCIPAL_INVESTIGATOR
Hopital Dupuytren Limoges
Isabelle BADELLON, Doctor
Role: PRINCIPAL_INVESTIGATOR
Fondation Rothschild Paris
Vincent BORDERIE, Professor
Role: PRINCIPAL_INVESTIGATOR
CHNO des quinze-vingts
Tristan BOURCIER, Professor
Role: PRINCIPAL_INVESTIGATOR
CHU de Strasbourg
Jean Louis BOURGES, Doctor
Role: PRINCIPAL_INVESTIGATOR
Hotel Dieu Paris
Dominique BREMOND GIGNAC, Professor
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire, Amiens
Carole BURILLON, Professor
Role: PRINCIPAL_INVESTIGATOR
Hopital Edouard Heriot Lyon
Philippe CAZEMIND, Doctor
Role: PRINCIPAL_INVESTIGATOR
Clinique du cours Dillion
Hervé CHENAL, Doctor
Role: PRINCIPAL_INVESTIGATOR
Joseph COLIN, Professor
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Bordeaux
Catherine CREUZOT GARCHER, Professor
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire Dijon
Stephan FAUQUIER, Doctor
Role: PRINCIPAL_INVESTIGATOR
Denis FLORES, Doctor
Role: PRINCIPAL_INVESTIGATOR
Philippe GAIN, Professor
Role: PRINCIPAL_INVESTIGATOR
CHU de Saint Etienne
Olivier Galatoire, Doctor
Role: PRINCIPAL_INVESTIGATOR
Fondation Rothschild Paris
Damien GATINEL, Doctor
Role: PRINCIPAL_INVESTIGATOR
Fondation Rothschild Paris
Jean Luc GEORGES, Professor
Role: PRINCIPAL_INVESTIGATOR
Central Hospital, Nancy, France
Thanh HOANG XUAN, Professor
Role: PRINCIPAL_INVESTIGATOR
Philippe IMBERT, Doctor
Role: PRINCIPAL_INVESTIGATOR
Polyclinique du Parc
Marc LABETOULLE, Professor
Role: PRINCIPAL_INVESTIGATOR
CH de Bicetre
Karim LAOUAR, Doctor
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier de Nimes
Sylvie MAES CASTELLARIN, Doctor
Role: PRINCIPAL_INVESTIGATOR
Hopital de Tarbes
Sylvie MAINGUY, Doctor
Role: PRINCIPAL_INVESTIGATOR
Claire MEURIOT TUIL, Doctor
Role: PRINCIPAL_INVESTIGATOR
Solange MILAZZO, Professor
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire, Amiens
Bruno MORTEMOUSQUE, Doctor
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Bordeaux
Pierre Jean PISELLA, Professor
Role: PRINCIPAL_INVESTIGATOR
CHU de Tours
Pierre Yves ROBERT, Professor
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Limoges
Stephane RONCIN, Doctor
Role: PRINCIPAL_INVESTIGATOR
Polyclinique Saint Laurent
Jean François ROULAND, Professor
Role: PRINCIPAL_INVESTIGATOR
CHU de Lille
Pierre LABALETTE, Professor
Role: PRINCIPAL_INVESTIGATOR
CHU de Lille
Frank ROUX, Doctor
Role: PRINCIPAL_INVESTIGATOR
HIA Laveran
Claude SPEEG, ¨Professor
Role: PRINCIPAL_INVESTIGATOR
CHU de Strasbourg
Michel TAZARTES, Doctor
Role: PRINCIPAL_INVESTIGATOR
Yves UTEZA, Doctor
Role: PRINCIPAL_INVESTIGATOR
Hatem ZEGHIDI, Doctor
Role: PRINCIPAL_INVESTIGATOR
Benoit BRIAT, Doctor
Role: PRINCIPAL_INVESTIGATOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU d'Amiens
Amiens, , France
Hopital Pellegrin
Bordeaux, , France
CHU de Dijon
Dijon, , France
76 Allée des Pins Tranquilles
Hossegord, , France
CHU de Bicêtre
Le Kremlin Bicêtre, , France
Hopital Claude Huriez
Lille, , France
Hopital Dupuytren
Limoges, , France
Hopital Edouard Heriot
Lyon, , France
433 bis rue Paradis
Marseille, , France
Hopital d'instruction des armées LAVERAN
Marseille, , France
67 chemin du Fescau
Montferrier-sur-Lez, , France
60 place Jacques Mirouze
Montpellier, , France
3 cours Leopold
Nancy, , France
Hopital Max Fourestier
Nanterre, , France
4 avenue Baquis
Nice, , France
Centre Hospitalier de Nimes
Nîmes, , France
22 rue Beaujon
Paris, , France
Hotel Dieu
Paris, , France
C.H.N.O des XV-XX
Paris, , France
142 Boulevard de Montparnasse
Paris, , France
Fondation Rothschild
Paris, , France
26 rue du Moulin des justices
Puilboreau, , France
Polyclinique Saint Laurent
Rennes, , France
CHU de Saint Etienne
Saint-Etienne, , France
CHU Hospices Civils
Strasbourg, , France
Hôpital de Tarbes
Tarbes, , France
Clinique du Cours Dillion
Toulouse, , France
CHU Bretonneau
Tours, , France
Hopital Brabois Adulte
Vandœuvre-lès-Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N° RCB 2010-A00199-30
Identifier Type: OTHER
Identifier Source: secondary_id
LT2420-PIV-CE-02/10
Identifier Type: -
Identifier Source: org_study_id